As a steroid hormone nuclear receptor, ERα can be bound and activated by estrogen 17β-estradiol (E2) and serves as a transcription factor for the transactivation of oncogenes, like c-Myc and cyclin D1, thereby promoting cell proliferation and tumor progression of BC (5–7). Here, CCND1 is linked to breast cancer.